
    
      The study will include 20 patients from up to four clinical sites in Australia. The overall
      treatment plan includes 2 weeks of inhalation treatments (intensive phase) of iNO four times
      per day at 4.5-hour intervals followed by 10 weeks of inhalation treatments (maintenance
      phase) at the maximum tolerated dose (a maximum of 250 ppm NO) inhaled twice daily.
    
  